Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04694014
Other study ID # IREC/2020/143 AN0003667W500G
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date October 15, 2020
Est. completion date June 30, 2021

Study information

Verified date December 2020
Source African Wood Inc
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Problem The study will address the problem that no studies have established the Emotional Intelligence (EI) skills required by leaders and managers to engage frontline healthcare professionals in crisis situation like Covid19 in Kenya Purpose The purpose of the qualitative exploratory study is to identify the EI skills Leaders and managers need to engage Frontline Healthcare Professionals in Crisis. The Research Question is: What are the EI skills leaders and managers need to engage frontline healthcare professionals (FHP) during crisis situations such as the Covid19 pandemic?


Description:

Hypothesis The Study hypothesis that Leaders and managers with appropriate emotional intelligence skills will engage frontline healthcare professionals in crisis situations resulting in desired outcomes Data Collection The data collection will start with a primer survey on surveymonkey.com, behavioral and cognitive assessments through The Predictive Index, emotional intelligence competence assessments through emco4.com, followed by semi-structured face to face or virtual interviews with the participants. The Survey data, Assessments and the transcribed semi-structured interviews will be depersonalized and made available for subsequent researchers. The Videos if any will be destroyed three years after transcription. Participants The 20 Participants will be selected from the population. The Study population is the number of experienced frontline healthcare professionals working in Busia County of Kenya. The County Department of Health will help in recruiting participants from doctors, nurses, and other frontline healthcare professionals. Data Analysis The Data will be analyzed using DiscoverText.com cloud-based platform applying two rounds of coding: first in Vivo coding will be applied then prior codes will be enforced. The Vivo codes will be in the participant's word and voice. Eight priori codes will be adopted from EI literature. Societal Benefits Society needs healthcare professionals to deal with crisis situations that place them in imperilment. The leaders have constraints of resources, time and advanced knowledge. This study seeks to seek out EI skills that will enable leaders to engage healthcare professionals while recognizing the humanity in them.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 20
Est. completion date June 30, 2021
Est. primary completion date May 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 67 Years
Eligibility Inclusion Criteria: Experience frontline healthcare professionals working in Busia County of Kenya Exclusion Criteria: - None healthcare professionals - healthcare professionals not working in Busia county

Study Design


Intervention

Behavioral:
EI Open ended Pre-Survey and Semi Structured Interview
Provide Interview questions via online survey with informed consent to the participants then contact a 60 minute member checking interview in person or virtually via recorded Zoom sessions for each participant
Behavioral and Cognitive Assessment
Use Predictive index for both cognitive and behavioral assessment of the paticipants
Geneva Emotional Competence Test (GECO)
Administer the Geneva Emotional Competence Test to each participant

Locations

Country Name City State
Kenya Alupe University College Busia

Sponsors (2)

Lead Sponsor Collaborator
African Wood Inc Alupe University College

Country where clinical trial is conducted

Kenya, 

References & Publications (5)

Boyatzis RE. The Behavioral Level of Emotional Intelligence and Its Measurement. Front Psychol. 2018 Aug 13;9:1438. doi: 10.3389/fpsyg.2018.01438. eCollection 2018. Review. — View Citation

Brackett MA, Salovey P. Measuring emotional intelligence with the Mayer-Salovery-Caruso Emotional Intelligence Test (MSCEIT). Psicothema. 2006;18 Suppl:34-41. Review. — View Citation

Ng JY, Ntoumanis N, Thøgersen-Ntoumani C, Deci EL, Ryan RM, Duda JL, Williams GC. Self-Determination Theory Applied to Health Contexts: A Meta-Analysis. Perspect Psychol Sci. 2012 Jul;7(4):325-40. doi: 10.1177/1745691612447309. — View Citation

Roth G, Vansteenkiste M, Ryan RM. Integrative emotion regulation: Process and development from a self-determination theory perspective. Dev Psychopathol. 2019 Aug;31(3):945-956. doi: 10.1017/S0954579419000403. Epub 2019 May 22. Review. — View Citation

Schlegel K, Mortillaro M. The Geneva Emotional Competence Test (GECo): An ability measure of workplace emotional intelligence. J Appl Psychol. 2019 Apr;104(4):559-580. doi: 10.1037/apl0000365. Epub 2018 Oct 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Emotional Intelligence Competences Frontline Healthcare Professional need in their Leaders The EI Competences that the participants stated that are needed from their leaders by questioner through study completion, an average of 1 year
Secondary EI Competence of Participants The Geneva Emotional Competence (GECO) test measure of EI for each participant compared the stated EI needed by Leaders through study completion, an average of 1 year
Secondary Participant Behavioral Analysis Behavioral Outcome by Predictive Index Proprietary scale through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure